Oppenheimer analyst Hartaj Singh assigned a Buy rating to Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price
Tag: VRTX
Vertex Pharmaceuticals (VRTX) Gets a Hold Rating from Maxim Group
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (NASDAQ: VRTX) and Global Blood Therapeutics (NASDAQ: GBT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals
Vertex Pharmaceuticals (VRTX) Received its Third Buy in a Row
After Oppenheimer and Merrill Lynch gave Vertex Pharmaceuticals (NASDAQ: VRTX) a Buy rating last month, the company received another Buy,
Vertex Pharmaceuticals (VRTX) Gets a Buy Rating from Oppenheimer
Oppenheimer analyst Hartaj Singh assigned a Buy rating to Vertex Pharmaceuticals (VRTX – Research Report) today and set a price
Vertex Pharmaceuticals (VRTX) Receives a Hold from Maxim Group
In a report issued on October 30, Jason McCarthy from Maxim Group reiterated a Hold rating on Vertex Pharmaceuticals (VRTX
Wall Street Analysts Are Neutral on Top Healthcare Picks
Analysts fell to the sidelines weighing in on Vertex Pharmaceuticals (VRTX – Research Report) and AxoGen (AXGN – Research Report)